Budget 2027 gives health €29.1bn. So why aren’t Mounjaro and Wegovy funded for obesity?
Budget 2027 gives Irish health €29.1bn. We examine Mounjaro and Wegovy funding, obesity costs in Ireland, and the NCPE’s €5.23bn budget-impact estimate.
EXPLORE A LITTLE FURTHER
Wegovy
5 stories from the Compound journal.
How long do you stay on Mounjaro or Wegovy?
How long do you stay on Mounjaro or Wegovy in Ireland? HSE guidance, withdrawal-trial evidence, weight regain, reviews, cost and reasons treatment may change.
Retatrutide Ireland: what is it, can you get it, and how does it compare with Mounjaro, Wegovy and Ozempic?
Retatrutide is not approved in Ireland in 2026. See its Phase 2/3 weight-loss results, safety, likely availability and how it compares with Mounjaro, Wegovy…
How to get Ozempic in Ireland: prescription, eligibility, cost and alternatives
How to get Ozempic in Ireland in 2026: prescription rules, HSE coverage, weight-loss use, cost, Wegovy and Mounjaro alternatives, and safe access.
GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and what the evidence says
Can you take Ozempic, Wegovy or Mounjaro during pregnancy? Irish guide to GLP-1 safety, washout periods, accidental exposure, breastfeeding and the latest…